• FEES
  • REQUEST AN APPOINTMENT
  • SUBSCRIBE TO OUR MAILING LIST
  • Contact Us
Direct Line +61 426 428 156
HealthFlex
×
  • HOME
  • i3 SERVICES
  • i3 SAMPLE PROJECTS
  • i3 REPORTS
  • i3 Clinical Trials Report
  • i3 SHOP
  • i3 PARTNERSHIPS
  • i3 QoW

iClinical: Data platform for virtual clinical trials

iClinical: Data platform for virtual clinical trials
October 22, 2018adminNewsUncategorized

As part of i3 Consult’s partnership with iClinical, we are pleased to announce the launch of iClinical’s Data Platform for Virtual Clinical Trials mobile app. This technology is destined to leverage clinical trial management and outcomes through data collection at the source of the trial app with secure FDA 21 CFR Part 11 compliance and real time analytics and trial automation. This application can reduce 20-30% clinical trial costs and accelerate the timeline to regulatory approval and market launch by 6 to 8 months. Therefore we look forward to introducing this smart and unique technology to our clinical trial business space.

Data collection at source on trial apps
➔ Data collection happens in front of the subject (eSource). Any patient reported outcomes, video, audio and medical devices data is collected at source.
➔ The AI based trial assistant (chatbot) enables real-time retrieval of protocol related information, it enables principal investigators to see more patients in lesser time.
➔ With reduced data cleaning and remote monitoring, we can drastically reduce study costs.
Secure and FDA 21 CFR Part 11 compliant
➔ Secure storage is in HIPAA compliant cloud servers. There is complete 21CFR Part 11 compliance, including audit trail of all the entered data, investigator signatures and secure access to the study tablets.
Real time trial analytics and trial automation
➔ Predictive analytics provides Pharma’s with the trajectory of the trial in real-time. This includes the endpoints, site status and study outcomes.
➔ Machine learning models are used to clean the trial data at source, they are also used to generate holistic patient profiles and optimize remote risk based monitoring.
Outcomes
➔ With reduced data cleaning and remote monitoring, we can drastically reduce study costs. For a typical phase 3 clinical trial, we can save 20-30% of trial costs and get the drug to market sooner by 6-8 months.
➔ The platform is future proof and is perfectly suited for running remote and adaptive trials.

Products like this stand testimony to the success of our partnership with iClinical. This indeed will be a game changer for delivery of projects with our clients and i3 Consult look forward to working with iClinical in implementing this technology. For further details please and to request a private demonstration kindly contact Sridhar Byrappa PhD, CEO of iClinical as in the contact details provided:
Sridhar Byrappa PhD
CEO, iClinical Inc
Ph: 415-996-6860
Email: sridhar@iclinical.co
Website: http://iclinical.co/ 
LinkedIn:https://www.linkedin.com/in/sridharbyrappa/

Best regards,
Dr. Wallace Macindoe,
CEO & Founder of i3 Consult.
i3 Consult- Integrated Intelligence for Healthcare Industries.

Add Comment Cancel

You must be logged in to post a comment.

Categories

  • News
  • Uncategorized

Recent Posts

  • 2021 Launch: BioPitch.Live
  • A Timely i3 Quote of the Week (i3 QoW)
  • Facing the Challenges in a COVID-19 Era
  • i3 Consult: Using block chain technology in clinical trials to better help our clients.
  • i3 Consult : i3 Framework Services

Recent Comments

    Archives

    • January 2021
    • July 2020
    • May 2020
    • December 2019
    • October 2019
    • September 2019
    • June 2019
    • April 2019
    • March 2019
    • February 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • April 2018
    • February 2018
    • December 2017
    • October 2017
    • September 2017
    • March 2017

    logo

    i3 Consult is endowed with a broad range and depth of in-house skills with specialist expertise consolidated from a stringent selection of outsourced associates.

    +61 426 428 156,+33 788914240

    i3consult@i3consult.com

    https://www.i3consult.com

    France Office: 3 Place de l’Eglise, Liglet, Vienne, 86290. Australia Office: 1001/160 Roma Street, Brisbane, Qld. Australia 4000.

    Latest News and Press Release

    • 2021 Launch: BioPitch.Live Jan 7

      To kick start 2021, i3 Consult in partnership with iClinical,...

    • A Timely i3 Quote of the Week (i3 QoW) Jul 8

      "Pandemic is not a word to use lightly or carelessly....

    • Facing the Challenges in a COVID-19 Era May 30

      First and foremost, i3 Consult hopes that you and your...

    • i3 Consult: Using block chain technology in clinical trials to better help our clients. Dec 2

      Reproducibility, data sharing, personal data privacy concerns and patient enrolment...

    Get Us on Social Media

    Tweet to Us on @i3_Consult

    Quick Links

    • HOME
    • i3 SERVICES
    • i3 SAMPLE PROJECTS
    • i3 REPORTS
    • i3 Clinical Trials Report
    • i3 SHOP
    • i3 PARTNERSHIPS
    • i3 QoW
    Copyright ©i3 Consult 2021 All rights reserved.
    Click this link to view our Privacy Policy